Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bronchodilators in asthma: bypassing controversies].

N A Rosário Filho1

  • 1Departmento de Pediatria, UFPR, Curitiba, PR.

Jornal De Pediatria
|September 1, 1996
PubMed
Summary

Beta 2-agonists provide relief for acute asthma but continuous use may increase airway hyperresponsiveness. Anti-inflammatory treatments are recommended alongside beta 2-agonists, especially with frequent use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful Allogenic Stem Cell Transplantation in Patients with Inherited CARD9 Deficiency.

Journal of clinical immunology·2019
Same author

p.Phe508del, p.Gly542X, p.Arg1162X, p.Asn1303Lys, and p.Lys683serfsX38 mutations in CF newborn screening of Brazilian children.

Clinical genetics·2017
Same author

Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthma.

Respiratory medicine·2013
Same author

Exercise-induced bronchospasm in obese adolescents.

Allergologia et immunopathologia·2009
Same author

Prevalence of symptoms of asthma, rhinitis, and atopic eczema in Brazilian adolescents related to exposure to gaseous air pollutants and socioeconomic status.

Journal of investigational allergology & clinical immunology·2007
Same author

Prevalence of rhinitis and related-symptoms in schoolchildren from different cities in Brazil.

Allergologia et immunopathologia·2004

Area of Science:

  • Pulmonology
  • Pharmacology

Context:

  • Inhaled bronchodilators, specifically beta 2-agonists, are standard treatments for acute asthma exacerbations.
  • Concerns exist regarding continuous beta 2-agonist monotherapy potentially increasing airway hyperresponsiveness and its association with asthma morbidity and mortality.

Purpose:

  • To review the role of inhaled beta 2-agonists in asthma management.
  • To discuss the risks associated with continuous beta 2-agonist use and the importance of anti-inflammatory therapies.

Summary:

  • Beta 2-agonists are effective for acute bronchospasm relief and exercise-induced bronchospasm prevention.
  • Continuous beta 2-agonist monotherapy does not address underlying airway inflammation and may be linked to adverse outcomes.
  • Long-acting beta 2-agonists may benefit moderate to severe asthma, but overuse of short-acting agents suggests a need for anti-inflammatory co-treatment.

Impact:

  • Highlights the critical need for anti-inflammatory medications in asthma management.
  • Informs clinical practice regarding appropriate use of beta 2-agonists.
  • Emphasizes the importance of addressing airway inflammation for better asthma control and reduced morbidity.

Related Experiment Videos